These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10556039)

  • 1. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
    Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
    J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths.
    Renner C; Baumgartner R; Noegel AA; Holak TA
    J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
    Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
    Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
    Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD
    Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
    Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
    EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COOH terminus of p18INK4C distinguishes function from p16INK4A.
    Gump J; Turner S; Koh J
    Cancer Res; 2001 May; 61(10):3863-8. PubMed ID: 11358797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
    J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein folding and stability of human CDK inhibitor p19(INK4d).
    Zeeb M; Rösner H; Zeslawski W; Canet D; Holak TA; Balbach J
    J Mol Biol; 2002 Jan; 315(3):447-57. PubMed ID: 11786024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb independent inhibition of cell growth by p15(INK4B).
    Aytac U; Konishi T; David H; Mendoza S; Miller CW
    Biochem Biophys Res Commun; 1999 Aug; 262(2):534-8. PubMed ID: 10462509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CDK inhibitor genes in immortalized and carcinoma derived breast cell lines.
    Zhou JN; Linder S
    Anticancer Res; 1996; 16(4A):1931-5. PubMed ID: 8712723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
    Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
    FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas.
    Kawamata N; Seriu T; Koeffler HP; Bartram CR
    Cancer; 1996 Feb; 77(3):570-5. PubMed ID: 8630967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4.
    Li J; Poi MJ; Qin D; Selby TL; Byeon IJ; Tsai MD
    Biochemistry; 2000 Feb; 39(4):649-57. PubMed ID: 10651629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
    Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
    Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A minimum folding unit in the ankyrin repeat protein p16(INK4).
    Zhang B; Peng Zy
    J Mol Biol; 2000 Jun; 299(4):1121-32. PubMed ID: 10843863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor p16INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism.
    Tevelev A; Byeon IJ; Selby T; Ericson K; Kim HJ; Kraynov V; Tsai MD
    Biochemistry; 1996 Jul; 35(29):9475-87. PubMed ID: 8755727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.